Co™™I™™Ee Opinion
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
CPT® New Codes 2019: Biopsy, Skin
Billing and Coding Update Alexander Miller, M.D. AAD Representative to the AMA CPT Advisory Committee New Skin Biopsy CPT® Codes It’s all about the Technique! SPEAKER: Alexander Miller, M.D. AAD Representative to the AMA -CPT Advisory Committee Chair AAD Health Care Finance Committee Arriving on January 1, 2019 New and Restructured Biopsy Codes Tangential biopsy Punch Biopsy Incisional Biopsy How Did We Get Here? CMS CY 2016 Biopsy codes (11100, 11101 identified as potentially mis-valued; high expenditure RUC Survey sent to AAD Members Specialty survey results are the only tool available to support code values Challenging survey results Survey revealed bimodal data distribution; CPT Codes 11100, 11101 referred to CPT for respondents were valuing different procedures restructuring Rationale for New Codes 11100; 11101 • Previous skin biopsy codes did not distinguish between the different biopsy techniques that were being used CPT Recommended technique specification in new biopsy codes • Will also provide for reimbursement commensurate with the technique used How Did We Get Here? • CPT Editorial Panel deleted 11100; 11101 February 2017 • 6 New codes created based on technique utilized • Each technique: primary code and add-on code March 2017 • RUC survey sent to AAD members April 2017 • Survey results presented to the RUC Biopsy Codes Effective Jan., 1, 2019 • Integumentary biopsy codes 11755 Biopsy of nail unit (plate, bed, matrix, hyponychium, proximal and lateral nail folds 11100, 11101 have been deleted 30100 Biopsy, intranasal • New -
NVA Research Update E- Newsletter September – October – November 2016
NVA Research Update E- Newsletter September – October – November 2016 www.nva.org __________________________ Vulvodynia The Vulvar Pain Assessment Questionnaire inventory. Dargie E, Holden RR, Pukall CF. Pain. 2016 Aug 1. https://www.ncbi.nlm.nih.gov/pubmed/27780177 Millions suffer from chronic vulvar pain (ie, vulvodynia). Vulvodynia represents the intersection of 2 difficult subjects for health care professionals to tackle: sexuality and chronic pain. Those with chronic vulvar pain are often uncomfortable seeking help, and many who do so fail to receive proper diagnoses. The current research developed a multidimensional assessment questionnaire, the Vulvar Pain Assessment Questionnaire (VPAQ) inventory, to assist in the assessment and diagnosis of those with vulvar pain. A large pool of items was created to capture pain characteristics, emotional/cognitive functioning, physical functioning, coping skills, and partner factors. The item pool was subsequently administered online to 288 participants with chronic vulvar pain. Of those, 248 participants also completed previously established questionnaires that were used to evaluate the convergent and discriminant validity of the VPAQ. Exploratory factor analyses of the item pool established 6 primary scales: Pain Severity, Emotional Response, Cognitive Response, and Interference with Life, Sexual Function, and Self-Stimulation/Penetration. A brief screening version accompanies a more detailed version. In addition, 3 supplementary scales address pain quality characteristics, coping skills, and the impact on one's romantic relationship. When relationships among VPAQ scales and previously researched scales were examined, evidence of convergent and discriminant validity was observed. These patterns of findings are consistent with the literature on the multidimensional nature of vulvodynia. The VPAQ can be used for assessment, diagnosis, treatment formulation, and treatment monitoring. -
Pelvic Floor Dysfunction UPDATE
Pelvic floor dysfunction UPDATE A. Rebecca Meekins, MD Cindy L. Amundsen, MD Dr. Meekins is a Fellow in Female Pelvic Dr. Amundsen is Roy T. Parker Professor in Medicine and Reconstructive Surgery, Obstetrics and Gynecology, Urogynecology Department of Obstetrics and Gynecology, and Reconstructive Pelvic Surgery; Associate Duke University School of Medicine, Professor of Surgery, Division of Urology; Durham, North Carolina. Program Director of the Female Pelvic Medicine and Reconstructive Surgery Fellowship; Program Director of K12 Multidisciplinary Urologic Research Scholars Program; Program Director of BIRCWH, Duke University Medical Center. The authors report no financial relationships relevant to this article. “To cysto or not to cysto?” that is the ongoing question surrounding the role of cystoscopy following benign gyn surgery. These authors review data on the procedure’s ability to detect injury, an ideal method for visualizing IN THIS ureteral efflux, and how universal cystoscopy can affect the ARTICLE rate of injury. Universal cystoscopy policy sing cystoscopy to evaluate ureteral ranges from 0.02% to 2% for ureteral injury page 28 efflux and bladder integrity following and from 1% to 5% for bladder injury.5,6 U benign gynecologic surgery increases In a recent large randomized controlled the detection rate of urinary tract injuries.1 trial, the rate of intraoperative ureteral Detecting ureteral Currently, it is standard of care to perform a obstruction following uterosacral ligament obstruction cystoscopy following anti-incontinence pro- suspension (USLS) was 3.2%.7 Vaginal vault page 29 cedures, but there is no consensus among suspensions, as well as other vaginal cuff ObGyns regarding the use of universal cys- closure techniques, are common procedures Media for efflux toscopy following benign gynecologic sur- associated with urinary tract injury.8 Addi- visualization 2 gery. -
ANMC Specialty Clinic Services
Cardiology Dermatology Diabetes Endocrinology Ear, Nose and Throat (ENT) Gastroenterology General Medicine General Surgery HIV/Early Intervention Services Infectious Disease Liver Clinic Neurology Neurosurgery/Comprehensive Pain Management Oncology Ophthalmology Orthopedics Orthopedics – Back and Spine Podiatry Pulmonology Rheumatology Urology Cardiology • Cardiology • Adult transthoracic echocardiography • Ambulatory electrocardiology monitor interpretation • Cardioversion, electrical, elective • Central line placement and venous angiography • ECG interpretation, including signal average ECG • Infusion and management of Gp IIb/IIIa agents and thrombolytic agents and antithrombotic agents • Insertion and management of central venous catheters, pulmonary artery catheters, and arterial lines • Insertion and management of automatic implantable cardiac defibrillators • Insertion of permanent pacemaker, including single/dual chamber and biventricular • Interpretation of results of noninvasive testing relevant to arrhythmia diagnoses and treatment • Hemodynamic monitoring with balloon flotation devices • Non-invasive hemodynamic monitoring • Perform history and physical exam • Pericardiocentesis • Placement of temporary transvenous pacemaker • Pacemaker programming/reprogramming and interrogation • Stress echocardiography (exercise and pharmacologic stress) • Tilt table testing • Transcutaneous external pacemaker placement • Transthoracic 2D echocardiography, Doppler, and color flow Dermatology • Chemical face peels • Cryosurgery • Diagnosis -
216 Does Episiotomy Influence Vaginal Resting Pressure, Pelvic Floor Muscle Strength and Endurance and Prevalence of Urinary
216 Bø K1, Hilde G2, Engh M E2 1. Norwegian School of Sport Sciences, 2. Akershus University Hospital DOES EPISIOTOMY INFLUENCE VAGINAL RESTING PRESSURE, PELVIC FLOOR MUSCLE STRENGTH AND ENDURANCE AND PREVALENCE OF URINARY INCONTINENCE SIX WEEKS POSTPARTUM? Hypothesis / aims of study Vaginal delivery is an established risk factor for weakening of the pelvic floor muscles (PFM) and development of pelvic floor dysfunctions such as urinary incontinence (UI) (1). The role of episiotomy on PFM function and prevalence of UI is debated and results differ between studies (1). The aim of the present study was to compare vaginal resting pressure (VRP), PFM strength and PFM endurance and prevalence of UI in women with and without lateral or mediolateral episiotomy six weeks postpartum. Study design, materials and methods Three hundred nulliparous pregnant women participating in a prospective cohort study giving birth at the same public hospital and able to understand the native language were recruited to the study. For this cross-sectional analysis six weeks postpartum only women with vaginal deliveries were included. Exclusion criteria were previous miscarriage after gestational week 16. Ongoing exclusion criteria were premature birth < 32 weeks, stillbirth and serious illness to mother or child. Lateral or mediolateral episiotomy was only performed on indications, e.g. foetal distress, imminent risk of severe perineal tear and in most cases when undergoing instrumental delivery. Vaginal resting pressure (cm H2O), PFM strength (cm H2O) and endurance (cm H2Osec) were assessed by a vaginal balloon connected to a high precision pressure transducer. The method has been found to be responsive, reliable and valid when used with simultaneous observation of inward movement of the perineum during contraction (2). -
Table of Contents
Society for Sex Therapy and Research SSTAR 2008: 33rd Annual Meeting Continuing Medical Education Credit is provided through joint sponsorship with The American College of Obstetricians and Gynecologists (ACOG). Intercontinental Hotel Chicago, Illinois USA March 13-15, 2008 TABLE OF CONTENTS President‘s Welcome ..........................................................................................................1 SSTAR 2009: 34th Annual Meeting – Arlington, Virginia, USA ........................................2 SSTAR 2008 Fall Clinical Meeting – New York, New York USA ....................................2 SSTAR Executive Council and Administrative Staff ..........................................................3 Continuing Education Accreditations & Approvals ............................................................5 Acknowledgements ..............................................................................................................6 Program Schedule ................................................................................................................7 2008 Award Recipients ....................................................................................................14 SSTAR Health Professional Book Award .............................................................14 Sex, Therapy, and Kids Recipient: Sharon Lamb, EdD SSTAR Service Award ..........................................................................................14 Recipient: Bill Maurice, MD SSTAR Student Research Award Abstract ............................................................15 -
A Clinical and Histological Study of Radiofrequency-Assisted Liposuction (RFAL) Mediated Skin Tightening and Cellulite Improvement ——RFAL for Skin Tightening
Journal of Cosmetics, Dermatological Sciences and Applications, 2011, 1, 36-42 doi:10.4236/jcdsa.2011.12006 Published Online June 2011 (http://www.SciRP.org/journal/jcdsa) A Clinical and Histological Study of Radiofrequency-Assisted Liposuction (RFAL) Mediated Skin Tightening and Cellulite Improvement ——RFAL for Skin Tightening Marc Divaris1, Sylvie Boisnic2, Marie-Christine Branchet2, Malcolm D. Paul3 1Plastic and Maxillo-Facial Surgery, University of Pitie Salpetiere, Paris, France; 2Institution GREDECO, Paris, France; 3Department of Surgery, Aesthetic and PlasticSurgery Institute, University of California, Irvine, USA. Email: [email protected] Received May 1st, 2011; revised May 27th, 2011; accepted June 6th, 2011. ABSTRACT Background: A novel Radiofrequency-Assisted Liposuction (RFAL) technology was evaluated clinically. Parallel origi- nal histological studies were conducted to substantiate the technology’s efficacy in skin tightening, and cellulite im- provement. Methods: BodyTiteTM system, utilizing the RFAL technology, was used for treating patients on abdomen, hips, flanks and arms. Clinical results were measured on 53 patients up to 6 months follow-up. Histological and bio- chemical studies were conducted on 10 donors by using a unique GREDECO model of skin fragments cultured under survival conditions. Fragments from RFAL treated and control areas were examined immediately and after 10 days in culture, representing long-term results. Skin fragments from patients with cellulite were also examined. Results: Grad- ual improvement in circumference reduction (3.9 - 4.9 cm) and linear contraction (8% - 38%) was observed until the third month. These results stabilized at 6 months. No adverse events were recorded. Results were graded as excellent by most patients, including the satisfaction from minimal pain, bleeding, and downtime. -
The Role of Pelvic Floor Muscles Dysfunction in Constipation
PHYSICAL TREA MENTS January 2015 . Volume 4 . Number 4 Systematic Review: The Role of Pelvic Floor Muscles Dysfunction in Constipation Andiya Bahmani 1*, Amir Masoud Arab 1, Bijan Khorasany 2, Shabnam Shahali 1, Mojgan Foroutan 3 1. Department of Physical Therapy, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. 2. Department of Clinical Sciences, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. 3. Department of Educational Designing & Curriculum Planning, School of Medical Education Sciences, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran. Article info: A B S T R A C T Received: 10 Aug. 2014 Accepted: 27 Nov. 2014 Purpose: Pelvic floor muscle dysfunction is a common cause of constipation. This dysfunction does not respond to current treatments of constipation. Thus, it is important to identify this type of dysfunction and the role of these muscles in constipation. The purpose of the present study was to review the previously published studies concerning the role of pelvic floor muscles dysfunction in constipation and related assessment methods. Methods: Articles were obtained by searching in several databases including, Elsevier, Science Direct, ProQuest, Google scholar, and PubMed. The keywords that were used were ‘constipation,’ ‘functional constipation,’ and ‘pelvic floor dysfunction.’ Inclusion criteria included articles that were published in English from 1980 to 2013. A total of 100 articles were obtained using the mentioned keywords that among them articles about constipation, its definition, types, methods of assessment, and diagnosis were reviewed. Of these articles, 12 articles were related to the assessment procedures and pelvic floor muscle function in constipation. -
Vulvar Pain Syndromes a Bounty of Treatments— but Not All of Them Are Proven
second of 3 parTs VulVar paIn syndroMes a bounty of treatments— but not all of them are proven Treatments for vulvodynia and vestibulodynia range from lifestyle adjustments and application of topical agents to tricyclic antidepressants and nerve blocks— but the data on their efficacy are not as bountiful neal M. lonky, Md, MpH, moderator; libby edwards, Md, Jennifer Gunter, Md, and Hope K. Haefner, Md, panelists s we discussed in the first installment vulva. Cool gel packs are sometimes helpful. of this three-part series in the Sep- In thIs When it comes to intercourse, I recom- Article A tember issue of OBG Management, mend adequate lubrication using any of a the causes of vulvar pain are many, and the number of effective products, such as olive Therapies discussed diagnosis of this common complaint can be oil, vitamin E oil, Replens, Slippery Stuff, As- by the panel difficult. Once the diagnosis of vulvodynia troglide, KY Liquid, and others. page 34 has been made, however, the challenge shifts There is an extensive list of lubricants at to finding an effective treatment. Here, our http://www.med.umich.edu/sexualhealth/ How to determine expert panel discusses the many options resources/guide.htm which treatments available, the data (or lack of it) behind each are best therapy, and what to do in refractory cases. In Part 3 of this series, in the November Topical agents might offer relief page 35 issue, the focus will be vestibulodynia. —but so might placebo Dr. Lonky: What is the role of topical medi- Is physical therapy cations, including anesthetics, for treating underrated? Management of vulvar pain vulvar pain syndromes? page 38 begins with simple measures Dr. -
Can Pelvic Floor Injury Secondary to Delivery Be Prevented?
Int Urogynecol J DOI 10.1007/s00192-011-1530-0 REVIEWARTICLE Can pelvic floor injury secondary to delivery be prevented? Yuval Lavy & Peter K. Sand & Chava I. Kaniel & Drorith Hochner-Celnikier Received: 28 March 2011 /Accepted: 21 July 2011 # The International Urogynecological Association 2011 Abstract The number of women suffering from pelvic Introduction floor disorders (PFD) is likely to grow significantly in the coming years with a growing older population. There is an “Be fruitful and multiply” is the first commandment urgent need to investigate factors contributing to the mentioned in the Bible (Genesis 1:28). However, after development of PFD and develop preventative strategies. Eve sinned by eating the apple from the tree in the Garden We have reviewed the literature and analyzed results from of Eden, the woman was cursed as follows: “It will be with our own study regarding the association between delivery anguish that you will give birth to children” (Genesis 3:16). mode, obstetrical practice and fetal measurements, and What does the word “anguish” imply? Pain, sorrow, damage to the pelvic floor. Based on our findings, we have discomfort, or insult to the pelvic floor? suggested a flowchart helping the obstetrician to conduct In this paper, we will try to answer two questions. First, vaginal delivery with minimal pelvic floor insult. Primi- is there an association between the natural process of parity, instrumental delivery, large fetal head circumference, birthing and damage to the pelvic floor, and do we have and prolonged second stage of delivery are risk factors for enough data on the impact of delivery mode on the pelvic PFD. -
The Clinical Role of LASER for Vulvar and Vaginal Treatments in Gynecology and Female Urology: an ICS/ISSVD Best Practice Consensus Document
Received: 30 November 2018 | Accepted: 3 January 2019 DOI: 10.1002/nau.23931 SOUNDING BOARD The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document Mario Preti MD1 | Pedro Vieira-Baptista MD2,3 | Giuseppe Alessandro Digesu PhD4 | Carol Emi Bretschneider MD5 | Margot Damaser PhD5,6,7 | Oktay Demirkesen MD8 | Debra S. Heller MD9 | Naside Mangir MD10,11 | Claudia Marchitelli MD12 | Sherif Mourad MD13 | Micheline Moyal-Barracco MD14 | Sol Peremateu MD12 | Visha Tailor MD4 | TufanTarcanMD15 | EliseJ.B.DeMD16 | Colleen K. Stockdale MD, MS17 1 Department of Obstetrics and Gynecology, University of Torino, Torino, Italy 2 Hospital Lusíadas Porto, Porto, Portugal 3 Lower Genital Tract Unit, Centro Hospitalar de São João, Porto, Portugal 4 Department of Urogynaecology, Imperial College Healthcare, London, UK 5 Center for Urogynecology and Pelvic Reconstructive Surgery, Obstetrics, Gynecology and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio 6 Glickman Urological and Kidney Institute and Department of Biomedical Engineering Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 7 Advanced Platform Technology Center, Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio 8 Faculty of Medicine, Department of Urology, Istanbul University Cerrahpaşa, Istanbul, Turkey 9 Department of Pathology and Laboratory Medicine, Rutgers-New Jersey Medical School, Newark, New Jersey 10 Kroto Research Institute, Department of Material Science and Engineering, -
Pelvic Floor Dysfunction EVIDENCE TABLE
ACR Appropriateness Criteria® Pelvic Floor Dysfunction EVIDENCE TABLE Patients/ Study Objective Study Reference Study Type Study Results Events (Purpose of Study) Quality 1. Sung VW, Hampton BS. Epidemiology of Review/Other- N/A To review the epidemiology of urinary Pelvic floor disorders are common and have a 4 pelvic floor dysfunction. Obstet Gynecol. Dx incontinence, POP, anal incontinence, and negative impact on a woman's quality of life. Clin North Am. 2009; 36(3):421-443. painful bladder conditions. Unfortunately most women do not seek care for these debilitating symptoms. Understanding risk factors, particularly modifiable factors, is critical for developing future prevention guidelines and improving the specificity of treatments. 2. Nygaard I, Bradley C, Brandt D. Pelvic Review/Other- 270 patients To estimate the prevalence of POP in older In 270 participants, age (mean +/- SD) was 4 organ prolapse in older women: Dx women using the POP-Q examination and to 68.3 +/- 5.6 years, body mass index was 30.4 prevalence and risk factors. Obstet identify factors associated with prolapse. +/- 6.2 kg/m(2), and vaginal parity (median Gynecol. 2004; 104(3):489-497. [range]) was 3 (0-12). The proportions of POP-Q stages (95% CIs) were stage 0, 2.3% (95% CI, 0.8%-4.8%); stage I, 33.0% (95% CI, 27.4%-39.0%); stage II, 62.9% (95% CI, 56.8%-68.7%); and stage III, 1.9% (95% CI, 0.6%-4.3%). In 25.2% (95% CI, 20.1%- 30.8%), the leading edge of prolapse was at the hymen or below.